![Dimitris Voliotis](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dimitris Voliotis
Technik-/Wissenschafts-/F&E-Leiter bei
RADIOPHARM THERANOSTICS LIMITED
Profil
Dimitris Voliotis currently works at Radiopharm Theranostics Ltd., as Chief Medical Officer from 2024.
Dr. Voliotis also formerly worked at CureVac SE, as Chief Development Officer from 2019 to 2020, Eisai, Inc., as Global Head-Clinical Development Oncology from 2016 to 2019, Bayer HealthCare AG, as Vice President & Head-Oncology Group from 2007 to 2014, and Zentalis Pharmaceuticals, Inc., as Senior Vice President-Clinical Development from 2020 to 2023.
Dr. Voliotis received his doctorate degree from Universität zu Köln.
Aktive Positionen von Dimitris Voliotis
| Unternehmen | Position | Beginn |
|---|---|---|
| RADIOPHARM THERANOSTICS LIMITED | Technik-/Wissenschafts-/F&E-Leiter | 20.08.2024 |
Ehemalige bekannte Positionen von Dimitris Voliotis
| Unternehmen | Position | Ende |
|---|---|---|
| ZENTALIS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.09.2023 |
CureVac SE
 CureVac SE BiotechnologyHealth Technology Develops tumor immunotherapies | Corporate Officer/Principal | 01.02.2020 |
Eisai, Inc.
 Eisai, Inc. Pharmaceuticals: MajorHealth Technology Manufacturers pharmaceutical products | Corporate Officer/Principal | 01.01.2019 |
Bayer HealthCare AG
 Bayer HealthCare AG Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals, healthcare supplements and crop herbicides | Corporate Officer/Principal | 01.09.2014 |
Ausbildung von Dimitris Voliotis
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
29
Beziehungen ersten Grades
6
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
CureVac SE
CureVac SE BiotechnologyHealth Technology Develops tumor immunotherapies | Health Technology |
Eisai, Inc.
Eisai, Inc. Pharmaceuticals: MajorHealth Technology Manufacturers pharmaceutical products | Health Technology |
Bayer HealthCare AG
Bayer HealthCare AG Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals, healthcare supplements and crop herbicides | Health Technology |
Universität zu Köln
 Universität zu Köln Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Zentalis Pharmaceuticals, Inc.
 Zentalis Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops clinical therapeutics for targeting fundamental cancer pathways | Health Technology |
Radiopharm Theranostics Ltd.
 Radiopharm Theranostics Ltd. Medical/Nursing ServicesHealth Services Provides nuclear diagnostic services | Health Services |
